Azenta to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
Azenta, Inc. (Nasdaq: AZTA) announced its participation in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 16, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Azenta, Inc. (Nasdaq: AZTA) announced its participation in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 16, 2022. The company, which recently rebranded from Brooks Automation, offers comprehensive life sciences solutions, enhancing drug development and clinical research efforts globally. Azenta specializes in cold-chain sample management and genomic services, supporting leading pharmaceutical and biotech firms.
Headquartered in Chelmsford, MA, Azenta operates in North America, Europe, and Asia. For more details, visit www.azenta.com.
Details
News Market Reaction – AZTA
The recorded move for AZTA in the trading session of this news was +2.32%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CHELMSFORD, Mass., Aug. 11, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 16, 2022.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. As of December 1st, the company changed its name and ticker to Azenta, Inc. (Nasdaq: AZTA) from Brooks Automation, Inc, (Nasdaq: BRKS).
Azenta is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.
INVESTOR CONTACT:
Sara Silverman
Head of Investor Relations
978.262.2635
IR@azenta.com
Sherry Dinsmore
Azenta Life Sciences
978.262.2400
sherry.dinsmore@azenta.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-7th-annual-needham-virtual-med-tech--diagnostics-1x1-conference-301604577.html
SOURCE Azenta, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.